Literature DB >> 16393285

Blood oxidative stress markers are unreliable markers of hepatic steatosis.

D Bonnefont-Rousselot1, V Ratziu, P Giral, F Charlotte, I Beucler, T Poynard.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) and viral hepatitis are associated with hepatic oxidative stress, which is partially dependent on the amount of hepatic fat. AIM: To determine whether the circulating lipid and oxidative stress parameters could be non-invasive markers of hepatic steatosis.
METHODS: Sixty-four patients with NAFLD or viral hepatitis were tested for lipid peroxidation products and antioxidant defence systems, lipid parameters and liver function tests.
RESULTS: Hepatic steatosis was correlated with lipids, gamma-glutamyltranspeptidase, thiobarbituric acid-reactive substances, superoxide dismutase and superoxide dismutase/erythrocyte glutathione peroxidase ratio. gamma-Glutamyltranspeptidase, triglycerides and low-density lipoprotein cholesterol were significantly higher in the presence of steatosis. No difference in blood oxidative stress markers was observed according to the presence or absence of steatosis except for the superoxide dismutase/erythrocyte glutathione peroxidase ratio. Total cholesterol, triglycerides and low-density lipoprotein cholesterol were significantly higher in the NAFLD group (n = 17, 60% mean steatosis grade) than in the viral hepatitis group (n = 20, 13% mean steatosis grade). Only superoxide dismutase was lower and vitamin E higher in NAFLD than in viral hepatitis patients.
CONCLUSIONS: Standard blood oxidative stress markers do not predict the extent of hepatic steatosis as they probably do not accurately reflect intrahepatic oxidative stress. Serum lipid levels were best correlated with hepatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393285     DOI: 10.1111/j.1365-2036.2006.02719.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

1.  Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet.

Authors:  Yildiz Öner-İyidoğan; Hikmet Koçak; Muhammed Seyidhanoğlu; Figen Gürdöl; Ahmet Gülçubuk; Funda Yildirim; Aydin Çevik; Müjdat Uysal
Journal:  J Physiol Biochem       Date:  2013-02-22       Impact factor: 4.158

Review 2.  Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.

Authors:  Kareem Hassan; Varun Bhalla; Mohammed Ezz El Regal; H Hesham A-Kader
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  Transcriptional profile of genes involved in oxidative stress and antioxidant defense in a dietary murine model of steatohepatitis.

Authors:  Agnieszka Gornicka; Gareth Morris-Stiff; Samjhana Thapaliya; Bettina G Papouchado; Michael Berk; Ariel E Feldstein
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 4.  Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.

Authors:  Pierluigi Marzuillo; Anna Grandone; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 5.  Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

6.  Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis.

Authors:  Man-Jie Zhu; Li-Juan Sun; Yue-Qin Liu; Yan-Ling Feng; Hai-Tao Tong; Ying-He Hu; Zheng Zhao
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

Review 7.  Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.

Authors:  Neven Baršić; Ivan Lerotić; Lea Smirčić-Duvnjak; Vedran Tomašić; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

8.  Moderate oxidative stress and high antioxidative activity are associated with steatosis in Japanese males.

Authors:  Takuya Imatoh; Seiichirou Kamimura; Shinichi Tanihara
Journal:  Clin Transl Sci       Date:  2012-12-06       Impact factor: 4.689

9.  Non alcoholic fatty liver disease and metabolic syndrome.

Authors:  P Paschos; K Paletas
Journal:  Hippokratia       Date:  2009-01       Impact factor: 0.471

10.  Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C.

Authors:  Robert P Myers; Djamila Messous; Thierry Poynard; Francoise Imbert-Bismut
Journal:  Can J Gastroenterol       Date:  2007-05       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.